Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Comorbidities of COPD in the Exacerbator Phenotype - A Cross Sectional Disease/Condition Focused Observational Study on COPD

NCT02100332 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02100332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02100332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Comorbidities of COPD in the Exacerbator Phenotype - A Cross Sectional Disease/Condition Focused Observational Study on COPD
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
July 31, 2014
Enrollment
860 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease